All COVID-19 articles – Page 7
-
NewsCentury-old vaccine protects type 1 diabetics from infectious diseases
Research shows that the 100-year-old Bacillus Calmette-Guérin (BCG) vaccine, originally developed to prevent tuberculosis, protects individuals with type 1 diabetes from severe COVID-19 disease and other infectious diseases.
-
NewsHow vaccine messaging is framed makes a difference, new research reveals
A one-size-fits-all approach to communicating the benefits of vaccines isn’t effective. Message framing plays a crucial role depending on the mindset, so it requires communicating in different ways for different people, a new study says.
-
NewsLong-term protection from SARS-CoV-2 variants in mice by a Phase II clinically evaluated original mRNA vaccine booster
A new study discusses the development of an mRNA vaccine (LVRNA009) that encoded the S protein of the Wuhan-Hu-1 strain and evaluated the long-term protection potential against SARS-CoV-2 variants.
-
NewsWearing face masks did not reduce risk of COVID infection after first Omicron wave, research shows
A study has found that wearing face masks did not lower the risk of Covid infection following the initial surge of the Omicron variant. Overseas travel was not associated with increased risk prior to February 2022, but then became a significant risk.
-
NewsVirus that causes COVID-19 can penetrate blood-retinal-barrier and could damage vision
Using a humanized mouse model, researchers have discovered the virus that causes COVID-19 can breach the protective blood-retinal barrier with potential long-term consequences in the eye.
-
NewsBiophysicist F. William Studier awarded Merkin prize in biomedical technology
F. William Studier, a senior biophysicist emeritus at the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory, has won the 2024 Richard N. Merkin Prize in Biomedical Technology for his development in the 1980s of an efficient, scalable method of producing RNA and proteins in the laboratory. Source: ...
-
NewsSARS-CoV-2 and type 1 diabetes in children: new study aims to explore the relationship
A new study will investigate whether vaccination against SARS-CoV-2 in the first year of life can protect children who have an increased genetic risk for type 1 diabetes from developing the condition.
-
NewsA third Covid vaccine dose improves defence for some clinically extremely vulnerable patients
A major clinical trial has found that an additional COVID 19 vaccine dose led to the majority of clinically extremely vulnerable people mounting defensive antibodies against Covid-19.
-
NewsAn adjuvant made in yeast could lower vaccine cost and boost availability
Scientists have wielded the power of synthetic biology to produce the active ingredient of soap bark, a molecule called QS-21, in yeast - a more environmentally friendly way to produce a key ingredient of vaccines.
-
NewsMobile teams bring COVID-19 vaccines to rural villages in Sierra Leone
A new international research project showed that intervention with mobile vaccination teams in Sierra Leone is an effective way of reaching rural populations to increase vaccination uptake.
-
NewsScience academies discuss global health approaches for future pandemics
Experts will discuss questions concerning global healthcare policy and pandemic prevention at the Leopoldina International Virtual Panel on Tuesday 14 May.
-
NewsTransfected SARS-CoV-2 spike DNA suppresses cancer cell response to chemotherapy
Researchers have examined the interaction between SARS-CoV-2 spike, p53 and MDM2 (E3 ligase, which mediates p53 degradation) in cancer cells using an immunoprecipitation assay.
-
NewsNew vaccine effective against coronaviruses that haven’t even emerged yet
Researchers have developed a new vaccine technology that has been shown in mice to provide protection against a broad range of coronaviruses with potential for future disease outbreaks - including ones we don’t even know about.
-
NewsStudy identifies immunity threshold for protection against COVID-19 in children
Researchers have found rather than antibodies, other arms of the immune system – T cells and memory B cells – provide durable protection against symptomatic SARS-CoV-2 infection in children.
-
NewsStudy finds diabetes drug reduces COVID-19 viral load and viral rebound
Researchers have found that metformin, a drug commonly used to treat diabetes, can decrease the amount of COVID-19 virus in the body and lower the chances of the virus coming back strongly after initial treatment.
-
NewsStudy: Long COVID symptoms in children vary by age
Symptoms associated with Long COVID in children differ based on the child’s age, according to a nationwide, multi-site study.
-
NewsGlobal study reveals stark differences between females and males in major causes of disease burden
Globally, there are substantial differences between females and males (aged 10 and older) when it comes to health, with limited progress in bridging these health gaps over the past 30 years, according to a new study.
-
NewsClosing the U.S./Mexico border during COVID-19 increased HIV transmission
When the border crossing separating San Diego, California, from Tijuana, Mexico, was closed during the COVID-19 pandemic, drug tourism from San Diego to Tijuana continued, providing a flow of people in both directions.
-
NewsScientists uncover how Parkinson’s disease symptoms may be exarcerbated by COVID-19 infection
A new study provides insights into specific genes that may serve as biomarkers for Parkinson’s Disease and highlights the potential interaction between PD and COVID-19.
-
NewsRapid nanoplasmonic-enhanced detection of SARS-CoV-2 and variants on DNA aptamer metasurfaces
The rapid nanoplasmonic-enhanced detection enabled by DNA aptamer metasurfaces holds promise for efficient screening of SARS-CoV-2 and its variants in clinical settings, airports, and other high-traffic areas.
